Literature DB >> 19067430

Differential susceptibility of P-glycoprotein deficient mice to colitis induction by environmental insults.

Elizabeth M Staley1, Trenton R Schoeb, Robin G Lorenz.   

Abstract

BACKGROUND: P-glycoprotein (P-gp), the product of the multidrug resistance gene (MDR), is an ATP-dependent transmembrane pump, which is expressed in multiple cell lineages including epithelial and hematopoetic cells. The human MDR gene is located on chromosome 7 (7q21.1), a susceptibility loci for inflammatory bowel disease (IBD). A significant number of IBD patients carry mutations in this gene and P-gp-deficient FVB/N mice develop a severe spontaneous colitis, characterized by impaired intestinal barrier function and immune reactivity to intestinal bacterial antigens.
METHODS: In this work we explored the role of mouse strain, as well as environmental insults, on the development of colonic inflammation in the absence of P-gp. Among the induction methods utilized, dextran sodium sulfate (DSS) disrupts the intestinal epithelium, while piroxicam is a nonsteroidal antiinflammatory (NSAID) drug that inhibits prostaglandin production and initiates colitis in IL10-deficient animals. Helicobacter bilis is a known mediator of bacterial-induced colitis.
RESULTS: We demonstrate that crossing this mutation onto the C57BL/6 strain confers protection from spontaneous colitis. C57BL/6.mdr1a-deficient animals demonstrated increased histological inflammation, colonic shortening, fecal blood, and reduced body weight after 7 days of treatment with 2.25% DSS. C57BL/6.mdr1a-deficient mice treated with piroxicam or infected with H. bilis showed no weight loss, or alterations in colonic histology.
CONCLUSIONS: These data indicate that the effects of P-gp deficiency are significantly modulated by background strain influences, but that the epithelium continues to have increased susceptibility to chemical injury in the C57BL/6 model.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19067430      PMCID: PMC2887754          DOI: 10.1002/ibd.20824

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  51 in total

1.  LPS-dependent cyclooxygenase-2 induction in human monocytes is down-regulated by IL-13, but not by IFN-gamma.

Authors:  T Endo; F Ogushi; S Sone
Journal:  J Immunol       Date:  1996-03-15       Impact factor: 5.422

2.  The continuing challenge of predictive factors in rheumatoid arthritis: prediction or association?

Authors:  D M van der Heijde
Journal:  J Rheumatol       Date:  1997-01       Impact factor: 4.666

Review 3.  Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2.

Authors:  W L Smith; R M Garavito; D L DeWitt
Journal:  J Biol Chem       Date:  1996-12-27       Impact factor: 5.157

4.  Inflammatory large bowel disease in immunodeficient rats naturally and experimentally infected with Helicobacter bilis.

Authors:  D C Haines; P L Gorelick; J K Battles; K M Pike; R J Anderson; J G Fox; N S Taylor; Z Shen; F E Dewhirst; M R Anver; J M Ward
Journal:  Vet Pathol       Date:  1998-05       Impact factor: 2.221

5.  Helicobacter bilis-induced inflammatory bowel disease in scid mice with defined flora.

Authors:  N H Shomer; C A Dangler; M D Schrenzel; J G Fox
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

6.  Differential susceptibility of inbred mouse strains to dextran sulfate sodium-induced colitis.

Authors:  M Mähler; I J Bristol; E H Leiter; A E Workman; E H Birkenmeier; C O Elson; J P Sundberg
Journal:  Am J Physiol       Date:  1998-03

7.  Novel regulation of cyclooxygenase-2 expression and prostaglandin E2 production by IFN-gamma in human macrophages.

Authors:  M Barrios-Rodiles; K Chadee
Journal:  J Immunol       Date:  1998-09-01       Impact factor: 5.422

8.  A novel model of inflammatory bowel disease: mice deficient for the multiple drug resistance gene, mdr1a, spontaneously develop colitis.

Authors:  C M Panwala; J C Jones; J L Viney
Journal:  J Immunol       Date:  1998-11-15       Impact factor: 5.422

9.  Selective neutralization of prostaglandin E2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo.

Authors:  J P Portanova; Y Zhang; G D Anderson; S D Hauser; J L Masferrer; K Seibert; S A Gregory; P C Isakson
Journal:  J Exp Med       Date:  1996-09-01       Impact factor: 14.307

10.  Evidence for the involvement of interleukin 10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2.

Authors:  G Strassmann; V Patil-Koota; F Finkelman; M Fong; T Kambayashi
Journal:  J Exp Med       Date:  1994-12-01       Impact factor: 14.307

View more
  14 in total

1.  Interferon-γ alters downstream signaling originating from epidermal growth factor receptor in intestinal epithelial cells: functional consequences for ion transport.

Authors:  Gisela Paul; Ronald R Marchelletta; Declan F McCole; Kim E Barrett
Journal:  J Biol Chem       Date:  2011-11-08       Impact factor: 5.157

2.  Critical role for P-glycoprotein expression in hematopoietic cells in the FVB.Mdr1a(-/-) model of colitis.

Authors:  Elizabeth M Staley; Reed A Dimmitt; Trenton R Schoeb; Scott M Tanner; Robin G Lorenz
Journal:  J Pediatr Gastroenterol Nutr       Date:  2011-12       Impact factor: 2.839

3.  Epithelial delamination is protective during pharmaceutical-induced enteropathy.

Authors:  Scott T Espenschied; Mark R Cronan; Molly A Matty; Olaf Mueller; Matthew R Redinbo; David M Tobin; John F Rawls
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-07       Impact factor: 11.205

4.  Validation studies for germ-free Smad3-/- mice as a bio-assay to test the causative role of fecal microbiomes in IBD.

Authors:  Jisun Paik; Stacey Meeker; Charlie C Hsu; Audrey Seamons; Olesya Pershutkina; Jessica M Snyder; Thea Brabb; Lillian Maggio-Price
Journal:  Gut Microbes       Date:  2019-05-29

5.  Altered generation of induced regulatory T cells in the FVB.mdr1a-/- mouse model of colitis.

Authors:  S M Tanner; E M Staley; R G Lorenz
Journal:  Mucosal Immunol       Date:  2012-08-08       Impact factor: 7.313

6.  Murine P-glycoprotein deficiency alters intestinal injury repair and blunts lipopolysaccharide-induced radioprotection.

Authors:  Elizabeth M Staley; Vanisha R Yarbrough; Trenton R Schoeb; Joseph G Daft; Scott M Tanner; Dennis Steverson; Robin G Lorenz
Journal:  Radiat Res       Date:  2012-07-10       Impact factor: 2.841

7.  Role of postnatal acquisition of the intestinal microbiome in the early development of immune function.

Authors:  Reed A Dimmitt; Elizabeth M Staley; Gin Chuang; Scott M Tanner; Thomas D Soltau; Robin G Lorenz
Journal:  J Pediatr Gastroenterol Nutr       Date:  2010-09       Impact factor: 2.839

8.  Intestinal P-glycoprotein exports endocannabinoids to prevent inflammation and maintain homeostasis.

Authors:  Rose L Szabady; Christopher Louissaint; Anneke Lubben; Bailu Xie; Shaun Reeksting; Christine Tuohy; Zachary Demma; Sage E Foley; Christina S Faherty; Alejandro Llanos-Chea; Andrew J Olive; Randall J Mrsny; Beth A McCormick
Journal:  J Clin Invest       Date:  2018-08-13       Impact factor: 14.808

9.  Novel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiology.

Authors:  Vibeke Andersen; Katrine Svenningsen; Lina Almind Knudsen; Axel Kornerup Hansen; Uffe Holmskov; Allan Stensballe; Ulla Vogel
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

10.  CSF-1 receptor-dependent colon development, homeostasis and inflammatory stress response.

Authors:  Duy Huynh; Dilara Akçora; Jordane Malaterre; Chee Kai Chan; Xu-Ming Dai; Ivan Bertoncello; E Richard Stanley; Robert G Ramsay
Journal:  PLoS One       Date:  2013-02-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.